UBS Says Abbott’s Legacy Drug Unit Has Hidden Biosimilar Upside
This is a short summary. The full story is published by Finimize.
Read full story at FinimizeJoin PharmaJungle & connect with verified pharma buyers Register Free
This is a short summary. The full story is published by Finimize.
Read full story at Finimize
Torrent Pharmaceuticals’ Q2 FY27 net profit fell 9.6% to Rs 534 crore, although revenue rose 50.8% to Rs 4,979 crore as expenses climbed 70.9%. Dr…

Group sales rose 8% in Swiss francs to CHF 16.13 billion, and Roche kept its 2026 growth outlook.
Palleon Pharmaceuticals, a clinical-stage biotechnology company developing glycan editing therapeutics for autoimmune disease and cancer, today…

He joins Lupin from Teva Pharmaceuticals, where he held several senior leadership roles since 2015, serving most recently as executive vice…
Get your company in front of buyers, manufacturers, and sourcing professionals on PharmaJungle - completely free for your first 30 days.
Exclusive introductory offer for new advertisers
Get offers from suppliers
Your product details and requirements may be published on the marketplace.
Fields marked with * are mandatory.